IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

JUAN LUIS PIMENTEL JR.

Allopathic & Osteopathic Physicians Internal Medicine Nephrology

NPI
1215923149
CMS profile
54437
Location
GREENSBORO, GA

General Payments · PY2018–2024

$4,088.96

  • Reported across 231 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$791.04

54 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Nephrology GA All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $694.73 40
Education $96.31 14

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Amgen Inc. $259.54 18
Acerta Pharma LLC $114.56 6
Retrophin, Inc. $84.51 15
Ardelyx, Inc. $64.16 3
Boehringer Ingelheim Pharmaceuticals, Inc. $50.67 2
Bayer HealthCare Pharmaceuticals Inc. $49.78 2
NOVARTIS PHARMACEUTICALS CORPORATION $48.40 2
Otsuka America Pharmaceutical, Inc. $46.29 2
AKEBIA THERAPEUTICS INC $24.61 1
Fresenius USA Marketing, Inc. $20.03 1
Novo Nordisk AS $14.81 1
Aurinia Pharma U.S., Inc. $13.68 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $407.41 20
PY2019 $459.98 26
PY2020 $448.71 17
PY2021 $367.39 21
PY2022 $827.26 41
PY2023 $787.17 52
PY2024 $791.04 54

Payment records · PY2024 (54)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AKEBIA THERAPEUTICS INC $24.61 11/13/2024 Education Undisputed 01/23/2026 1145834307 CMS
Amgen Inc. $33.32 01/06/2024 Food and Beverage Undisputed 01/23/2026 1111677317 CMS
Amgen Inc. $12.21 02/01/2024 Food and Beverage Undisputed 01/23/2026 1111677319 CMS
Amgen Inc. $9.55 02/20/2024 Food and Beverage Undisputed 01/23/2026 1111677323 CMS
Amgen Inc. $8.63 03/07/2024 Food and Beverage Undisputed 01/23/2026 1111677321 CMS
Amgen Inc. $13.97 03/20/2024 Food and Beverage Undisputed 01/23/2026 1111677325 CMS
Amgen Inc. $11.99 04/09/2024 Food and Beverage Undisputed 01/23/2026 1111677327 CMS
Amgen Inc. $11.82 05/14/2024 Food and Beverage Undisputed 01/23/2026 1111677329 CMS
Amgen Inc. $1.54 05/14/2024 Food and Beverage Undisputed 01/23/2026 1111677331 CMS
Amgen Inc. $21.67 05/23/2024 Food and Beverage Undisputed 01/23/2026 1111677333 CMS
Amgen Inc. $6.75 06/25/2024 Food and Beverage Undisputed 01/23/2026 1111677349 CMS
Amgen Inc. $11.92 06/26/2024 Food and Beverage Undisputed 01/23/2026 1111677335 CMS
Amgen Inc. $10.43 07/17/2024 Food and Beverage Undisputed 01/23/2026 1111677337 CMS
Amgen Inc. $10.30 07/25/2024 Food and Beverage Undisputed 01/23/2026 1111677339 CMS
Amgen Inc. $25.21 08/05/2024 Food and Beverage Undisputed 01/23/2026 1111677341 CMS
Amgen Inc. $7.56 08/06/2024 Food and Beverage Undisputed 01/23/2026 1111677343 CMS
Amgen Inc. $19.63 10/03/2024 Food and Beverage Undisputed 01/23/2026 1111677351 CMS
Amgen Inc. $17.35 10/14/2024 Food and Beverage Undisputed 01/23/2026 1111677345 CMS
Amgen Inc. $25.69 11/12/2024 Food and Beverage Undisputed 01/23/2026 1111677347 CMS
Ardelyx, Inc. $32.08 01/18/2024 Food and Beverage Undisputed 01/23/2026 1146701090 CMS
Ardelyx, Inc. $15.46 04/24/2024 Food and Beverage Undisputed 01/23/2026 1146701092 CMS
Ardelyx, Inc. $16.62 07/24/2024 Food and Beverage Undisputed 01/23/2026 1146701094 CMS
AstraZeneca Pharmaceuticals LP $18.73 02/08/2024 Food and Beverage Undisputed 01/23/2026 1105306198 CMS
AstraZeneca Pharmaceuticals LP $21.29 04/25/2024 Food and Beverage Undisputed 01/23/2026 1104435907 CMS
AstraZeneca Pharmaceuticals LP $17.47 05/07/2024 Food and Beverage Undisputed 01/23/2026 1105883657 CMS
AstraZeneca Pharmaceuticals LP $17.37 06/25/2024 Food and Beverage Undisputed 01/23/2026 1105613887 CMS
AstraZeneca Pharmaceuticals LP $20.78 09/30/2024 Food and Beverage Undisputed 01/23/2026 1105318463 CMS
AstraZeneca Pharmaceuticals LP $18.92 11/11/2024 Food and Beverage Undisputed 01/23/2026 1105622163 CMS
Aurinia Pharma U.S., Inc. $13.68 04/23/2024 Food and Beverage Undisputed 01/23/2026 1150689777 CMS
Bayer Healthcare Pharmaceuticals Inc. $17.76 05/08/2024 Food and Beverage Undisputed 01/23/2026 1086170790 CMS
Bayer Healthcare Pharmaceuticals Inc. $32.02 12/09/2024 Food and Beverage Undisputed 01/23/2026 1086147729 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $26.43 02/07/2024 Food and Beverage Undisputed 01/23/2026 1117920231 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $24.24 08/22/2024 Food and Beverage Undisputed 01/23/2026 1117920229 CMS
Fresenius USA Marketing, Inc. $20.03 02/05/2024 Food and Beverage Undisputed 01/23/2026 1154194262 CMS
Novartis Pharmaceuticals Corporation $31.54 02/01/2024 Food and Beverage Undisputed 01/23/2026 1087316717 CMS
Novartis Pharmaceuticals Corporation $16.86 04/03/2024 Food and Beverage Undisputed 01/23/2026 1087316719 CMS
Novo Nordisk Inc $14.81 10/17/2024 Food and Beverage Undisputed 01/23/2026 1096696102 CMS
Otsuka America Pharmaceutical, Inc. $19.73 04/22/2024 Food and Beverage Undisputed 01/23/2026 1118961673 CMS
Otsuka America Pharmaceutical, Inc. $26.56 11/13/2024 Food and Beverage Undisputed 01/23/2026 1118961675 CMS
Travere Therapeutics, Inc. $3.08 01/17/2024 Education Undisputed 01/23/2026 1149941485 CMS
Travere Therapeutics, Inc. $16.89 01/17/2024 Education Undisputed 01/23/2026 1149941513 CMS
Travere Therapeutics, Inc. $3.08 02/14/2024 Education Undisputed 01/23/2026 1149941489 CMS
Travere Therapeutics, Inc. $16.89 02/14/2024 Education Undisputed 01/23/2026 1149941517 CMS
Travere Therapeutics, Inc. $0.37 05/09/2024 Education Undisputed 01/23/2026 1149941466 CMS
Travere Therapeutics, Inc. $3.08 05/09/2024 Education Undisputed 01/23/2026 1149941493 CMS
Travere Therapeutics, Inc. $0.37 06/03/2024 Education Undisputed 01/23/2026 1149941469 CMS
Travere Therapeutics, Inc. $1.28 06/03/2024 Food and Beverage Undisputed 01/23/2026 1149941481 CMS
Travere Therapeutics, Inc. $3.08 06/03/2024 Education Undisputed 01/23/2026 1149941498 CMS
Travere Therapeutics, Inc. $11.53 06/03/2024 Food and Beverage Undisputed 01/23/2026 1149941509 CMS
Travere Therapeutics, Inc. $16.89 06/03/2024 Education Undisputed 01/23/2026 1149941521 CMS
Travere Therapeutics, Inc. $0.37 09/05/2024 Education Undisputed 01/23/2026 1149941473 CMS
Travere Therapeutics, Inc. $3.08 09/05/2024 Education Undisputed 01/23/2026 1149941502 CMS
Travere Therapeutics, Inc. $4.15 09/05/2024 Education Undisputed 01/23/2026 1149941506 CMS
Travere Therapeutics, Inc. $0.37 10/28/2024 Education Undisputed 01/23/2026 1149941477 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.